Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PAY | SPHR |
|---|---|---|
| Price | $31.62 | $110.80 |
| Change today | ▲ 2.56% | ▼ 13.61% |
| Market cap | $3.98B | $3.98B |
| Return, 3 months | +10.9% | -29.2% |
| Return, year to date | +0.1% | +16.5% |
| Return, 1 year | -4.2% | +74.7% |
| P/E (TTM) | 47.9 | -57.1 |
| P/B | 6.5 | 1.8 |
| P/E percentile vs own 5y | – | 4th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +28.8% | +11.0% |
| Net profit growth (YoY) | +73.8% | -125.2% |
| Gross margin | 26.1% | 51.8% |
| Operating margin | 9.0% | -19.4% |
| Net margin | 7.1% | -12.2% |
| Return on equity | – | – |
| Analyst target vs. price | +31.8% | +55.9% |
| Analyst buy share | 50% | 78% |
| RSI (14) | 42 | 22 |
| 30-day volatility | 49.1% | 56.5% |
| Max drawdown, 1 year | -46.5% | -37.2% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
